|
Resistance prevalence of eight common bacteria, U.S. (all patients pooled), 1999–2002 |
||||||||
| unit: % |
||||||||
|
|
||||||||
| Bacterium |
Resistant to antibiotic(s) |
1999 |
2000 |
2001 |
2002 |
Average Resistance |
Average Growth Rate |
|
|
|
||||||||
| PAE |
Ciprofloxacin/ofloxacin |
23 |
25 |
28 |
29 |
26 |
8 |
|
| Levofloxacin |
29 |
30 |
31 |
30 |
30 |
1 |
||
| Imipenem |
12 |
12 |
15 |
13 |
13 |
4 |
||
| Ceftazidime |
8 |
8 |
9 |
9 |
9 |
4 |
||
| Piperacillin |
10 |
10 |
11 |
12 |
11 |
6 |
||
| SAU (MRSA) |
Methicillin |
32 |
35 |
38 |
39 |
36 |
7 |
|
| Enterococcus spp |
Vancomycin |
11 |
8 |
10 |
10 |
10 |
-1 |
|
| ECO |
Cef3 |
1 |
1 |
1 |
1 |
1 |
0 |
|
| Quinolone |
2 |
3 |
4 |
5 |
4 |
36 |
||
| KPN |
Cef3 |
4 |
4 |
4 |
5 |
4 |
8 |
|
| Enterobacter spp |
Cef3 |
19 |
19 |
18 |
19 |
19 |
0 |
|
| Carbapenum |
1 |
1 |
1 |
1 |
1 |
0 |
||
| CNS |
Methicillin |
60 |
61 |
62 |
63 |
62 |
2 |
|
| Pneumococcus spp |
Penicillin |
14 |
16 |
19 |
19 |
17 |
11 |
|
| Cef3 |
5 |
8 |
7 |
7 |
7 |
16 |
||
| Mean: |
17 |
7 |
||||||
Zhang et al. Globalization and Health 2006 2:6 doi:10.1186/1744-8603-2-6 |
||||||||